CoChat

Herceptin: From the Bench to the Clinic

Colomer, R., Shamon, L. A., Tsai, M. S., Lupu, R. · 2001 · Cancer Investigation

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

Polypeptide growth factors play important roles in both normal and pathological development of the breast. Such growth factors promote cell proliferation, motility, and invasiveness of epithelial c...

Overview

Integrity signals

Registry

Crossref · 10.1081/cnv-100000074

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 40 references

Research works printed but not linked: 5

  1. 10.1128/mcb.9.3.1165-1172.1989 · doi:10.1128/mcb.9.3.1165-1172.1989 · Paper page
  2. Cobleigh M. A., Vogel C. L., Tripathy N. J., et al. Efficacy and Safety of Herceptin (humanized Anti-HER-2 Antibody) as a Single Agent in 222 Women with HER-2 Overexpression Who Relapsed Following Chemotherapy for Metastatic Breast Cancer [Abstract 376]. Proc. Am. Soc. Clin. Oncol. 1998; 16: 376
  3. Vogel C. L. Cobleigh M. A. Tripathy D. et al. Efficacy and Safety of Herceptin (Trastuzumab Humanized Anti-HER-2 Antibody) as a Single Agent in First-Line Treatment of HER-2 Overexpressing Metastatic Breast Cancer (HER−2+/MBC) [Abstract 23]. 21st Annual San Antonio Breast Cancer Symposium. San Antonio TX 1998
  4. Norton L., Slamon D., Leyland-Jones B., Wolter J., Flaming T., Eirmann W., Baselga J., Mendelsohn J., Bajamonde A., Ash M., Shak S. Overall Survival Advantage to Simultaneous Chemotherapy Plus the Humanized Anti-HER2 Monoclonal Antibody Herceptin in HER2-overexpressiong Metastatic Breast Cancer [Abstract 483]. Proc. Am. Soc. Clin. Oncol. 1998; 18: 127
  5. Hudis C. Seidman A. Paton V. et al. Characterization of Cardiac Dysfunction in the Herceptin (Trastuzumab) Clinical Trials [Abstract 24]. 21st Annual San Antonio Breast Cancer Symposium. San Antonio TX 1998

Cited by

See all 43

Metadata

Authors
Colomer, R., Shamon, L. A., Tsai, M. S., & Lupu, R.
Affiliations
  • Hospital Universitario 12 De Octubre (ES)
  • Lawrence Berkeley National Laboratory (US)
Venue
Cancer Investigation
Published
2001-01
Volume
19
Issue
1
Pages
49-56
ISSN
  • 0735-7907 (ISSN-L)
  • 1532-4192
OpenAlex
W2014184151
Cited by
43
References
40
Citations by year
2025: 2 · 2024: 1 · 2020: 1 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 1
FWCI
2.92
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Investigation (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
  • Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
Keywords
trastuzumab, HER2/neu, peptide growth factors, breast cancer, breast development, cell proliferation, tumor invasion
MeSH terms
Trastuzumab, Animals, Antibodies, Monoclonal, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Clinical Trials as Topic, Female, Heart, Humans, Neoplasm Metastasis, Erb-b2 Receptor Tyrosine Kinases, Antibodies, Monoclonal, Humanized

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.